» Articles » PMID: 26840296

Clinical Genetic Aspects of ASD Spectrum Disorders

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2016 Feb 4
PMID 26840296
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Early presumptions opined that autism spectrum disorder (ASD) was related to the rearing of these children by emotionally-distant mothers. Advances in the 1960s and 1970s clearly demonstrated the biologic basis of autism with a high heritability. Recent advances have demonstrated that specific etiologic factors in autism spectrum disorders can be identified in 30%-40% of cases. Based on early reports newer, emerging genomic technologies are likely to increase this diagnostic yield to over 50%. To date these investigations have focused on etiologic factors that are largely mono-factorial. The currently undiagnosed causes of ASDs will likely be found to have causes that are more complex. Epigenetic, multiple interacting loci, and four dimensional causes (with timing as a variable) are likely to be associated with the currently unidentifiable cases. Today, the "Why" is more important than ever. Understanding the causes of ASDs help inform families of important issues such as recurrence risk, prognosis, natural history, and predicting associated co-morbid medical conditions. In the current era of emerging efforts in "personalized medicine", identifying an etiology will be critical in identifying endo-phenotypic groups and individual variations that will allow for tailored treatment for persons with ASD.

Citing Articles

Genetic etiology of autism spectrum disorder in the African population: a scoping review.

Hakizimana O, Hitayezu J, Uyisenga J, Onohuean H, Palmeira L, Bours V Front Genet. 2024; 15:1431093.

PMID: 39391062 PMC: 11464363. DOI: 10.3389/fgene.2024.1431093.


Genetic Testing History in Adults with Autism Spectrum Disorder.

Mierau S, Thom R, Ravichandran C, Nagy A, Rice C, Macenski C medRxiv. 2024; .

PMID: 39228695 PMC: 11370500. DOI: 10.1101/2024.08.18.24312179.


Parental Competences and Stress Levels in Mothers of Children with Autism Spectrum Disorders and Children Developing Neurotypically.

Tyszkiewicz-Gromisz B, Burdzicka-Wolowik J, Tymosiewicz P, Gromisz W J Clin Med. 2024; 13(4).

PMID: 38398430 PMC: 10889242. DOI: 10.3390/jcm13041119.


Microglia heterogeneity in health and disease.

Dadwal S, Heneka M FEBS Open Bio. 2023; 14(2):217-229.

PMID: 37945346 PMC: 10839410. DOI: 10.1002/2211-5463.13735.


Modern Biomarkers for Autism Spectrum Disorder: Future Directions.

Jensen A, Lane A, Werner B, McLees S, Fletcher T, Frye R Mol Diagn Ther. 2022; 26(5):483-495.

PMID: 35759118 PMC: 9411091. DOI: 10.1007/s40291-022-00600-7.


References
1.
Mohr Jensen C, Steinhausen H, Lauritsen M . Time trends over 16 years in incidence-rates of autism spectrum disorders across the lifespan based on nationwide Danish register data. J Autism Dev Disord. 2014; 44(8):1808-18. DOI: 10.1007/s10803-014-2053-6. View

2.
Hoffbuhr K, Devaney J, LaFleur B, Sirianni N, Scacheri C, Giron J . MeCP2 mutations in children with and without the phenotype of Rett syndrome. Neurology. 2001; 56(11):1486-95. DOI: 10.1212/wnl.56.11.1486. View

3.
Wood C, Warnell F, Johnson M, Hames A, Pearce M, McConachie H . Evidence for ASD recurrence rates and reproductive stoppage from large UK ASD research family databases. Autism Res. 2014; 8(1):73-81. DOI: 10.1002/aur.1414. View

4.
Eriksson M, Westerlund J, Anderlid B, Gillberg C, Fernell E . First-degree relatives of young children with autism spectrum disorders: some gender aspects. Res Dev Disabil. 2012; 33(5):1642-8. DOI: 10.1016/j.ridd.2012.03.025. View

5.
Zecavati N, Spence S . Neurometabolic disorders and dysfunction in autism spectrum disorders. Curr Neurol Neurosci Rep. 2009; 9(2):129-36. DOI: 10.1007/s11910-009-0021-x. View